… represents a cost-effective treatment option versus warfarin and aspirin for the prevention
of stroke in patients with AF from a Greek healthcare payer perspective over a lifetime horizon. …

… warfarin and aspirin among those patients who were unsuitable or refused to receive warfarin
… , organizational, and cost perspective on the Greek healthcare system is necessary to …

… mg in the setting of co-administration with aspirin and clopidogrel. Interestingly, only 9 out of
… drug was not available in Greece [18]. A significant trend of aspirin omission at discharge [19…

… ≥80 years) versus warfarin and “real-world” prescribing (ie warfarin, aspirin, or no treatment,
in a cohort of warfarin-eligible patients) from a Canadian payer perspective, for AF patients …

… Approximately 38% of patients with a gastrointestinal bleed were on aspirin before the
event… with warfarin; this association was attributed to the higher use of concomitant aspirin. …

… clinical trial CAPRIE from Ukrainian perspective. METHODS: … warfarin and aspirin for the
management of VKA-suitable and VKA-unsuitable patients with NVAF, respectively, in Greece…

… a superior clinical profile compared to warfarin and aspirin in the management of patients
with … against warfarin and aspirin for the prevention of stroke in patients with NVAF in Greece. …

… In the Greek population, the overall incidence of first stroke … Aspirin remains the first choice
and should be combined with … a promising alternative to warfarin for the primary prevention …

… (VKA) and aspirin in patients requiring stroke … to warfarin in prevention of stroke and systemic
embolism, bleeding risk, and mortality. 3 Furthermore, apixaban was superior to aspirin in …

… with triple therapy with warfarin plus a P2Y 12 inhibitor and aspirin 100 mg for 1–12 months
[46]. Regarding the primary endpoint of major or clinically relevant non-major bleeding, the …